Option Care Health, Inc. (NASDAQ:OPCH) Shares Bought by JPMorgan Chase & Co.

JPMorgan Chase & Co. increased its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 29.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,511,403 shares of the company’s stock after acquiring an additional 344,875 shares during the period. JPMorgan Chase & Co. owned approximately 0.89% of Option Care Health worth $35,065,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the stock. Murphy & Mullick Capital Management Corp acquired a new position in shares of Option Care Health in the 4th quarter valued at about $26,000. UMB Bank n.a. lifted its position in Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after buying an additional 346 shares in the last quarter. Signaturefd LLC grew its stake in Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock worth $28,000 after buying an additional 1,005 shares during the period. Blue Trust Inc. raised its stake in shares of Option Care Health by 16.9% in the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock valued at $109,000 after acquiring an additional 681 shares during the period. Finally, Venturi Wealth Management LLC lifted its holdings in shares of Option Care Health by 2,621.3% during the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock valued at $110,000 after acquiring an additional 4,561 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Stock Down 2.0 %

Shares of NASDAQ:OPCH opened at $32.87 on Tuesday. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a market cap of $5.40 billion, a PE ratio of 27.62, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. The company has a fifty day simple moving average of $33.00 and a 200 day simple moving average of $28.50.

Insider Transactions at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.64% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on OPCH shares. Barrington Research raised their price objective on Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, February 27th. Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and raised their target price for the company from $26.00 to $33.00 in a report on Monday, January 13th. JMP Securities restated a “market outperform” rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Finally, JPMorgan Chase & Co. upped their target price on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $33.00.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.